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PERIPHERAL NERVE SURGERY AND RESEARCHThe Key Components of Schwann Cell-like Differentiation Medium
and their Effects on Gene Expression Pattern of
Adipose-Derived Stem Cells
Hakan Orbay, MD, PhD,* Christopher J. Little, BS,* Lee Lankford, MS,* Christine A. Olson, BS,*
and David E. Sahar, MD*†Background: Schwann cell-like cells differentiated from adipose-derived stem
cells may have an important role in peripheral nerve regeneration. Herein,
we document the individual effects of growth factors in Schwann cell-like differ-
entiation medium.
Methods: There were 6 groups in the study. In the control group, we supple-
mented the rat adipose–derived stem cells with normal cell culture medium. In
group 1, we fed the cells with Schwann cell-like differentiation medium (normal
cell culture medium supplemented with platelet-derived growth factor, basic fi-
broblast growth factor, forskolin, and glial growth factor). In the other groups,
we removed the components of the medium one at a time from the differentiation
medium so that group 2 lacked glial growth factor, group 3 lacked forskolin,
group 4 lacked basic fibroblast growth factor, and group 5 lacked platelet-
derived growth factor. We examined the expression of the Schwann cell–specific
genes with quantitative reverse transcription polymerase chain reaction and im-
munofluorescence staining in each group.
Results:Groups 3 and 4, lacking forskolin and basic fibroblast growth factor, re-
spectively, had the highest expression levels of integrin-β4, and p75. Group 1
showed a 3.2-fold increase in the expression of S100, but the expressions of
integrin-β4 and p75 were significantly lower compared to groups 3 and 4. Group
2 [glial growth factor (−)] did not express significant levels of Schwann cell–specific
genes. The gene expression profile in group 4 most closely resembled Schwann
cells. Immunofluorescence staining results were parallel with the quantitative
real-time polymerase chain reaction results.
Conclusions: Glial growth factor is a key component of Schwann cell-like
differentiation medium.
Key Words: adipose-derived stem cells, Schwann cells, peripheral nerve injury
(Ann Plast Surg 2015;74: 584–588)
P eripheral nervous system has limited regenerative capacity. Al-though this regeneration capability can heal simple cuts of periph-
eral nerves satisfactorily, it is not sufficient for healing in case of larger
nerve defects.1,2 The distance and speed of regeneration in nerve de-
fects can be improved by adding stem cells (SCs) to the defect
zone.1,3,4 However, SC therapy is limited by donor tissue availabil-
ity, donor site morbidity, and long culture times.5–9 Therefore, recent
research is actively focusing on finding alternative sources for SCs.10Received August 12, 2014, and accepted for publication, after revision, December
12, 2014.
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Copyright © 2015 Wolters Kluwer HAdipose-derived mesenchymal SCs (ASCs) can be differentiated into
SC-like cells via coculture with SCs or more commonly with a mixture
of growth factors (GFs).11–13 Although these methods are both effective,
they are usually too complicated and expensive for rapid clinical trans-
lation. A better understanding of the roles of GFs used to induce the
ASCs into SC-like cells is crucial to facilitate the clinical translation of
SC therapy.
In this study, we examined the individual effects of GFs in
ASCs-SC differentiation medium by observing the changes in gene ex-
pression patterns of ASCs in response to the removal of the components
(one at a time) from the differentiation medium.MATERIALS AND METHODS
All animal procedures were performed following the guidelines
of Institutional Animal Care and Use Committee (IACUC approval
#16662) and the National Institutes of Health and any national law on
the care and use of laboratory animals.
Harvesting of ASCs
Adipose-derived stem cells were harvested from the inguinal
fat pads of female Lewis rats by enzymatic digestion as described
elsewhere.14 The cells in culture flasks were maintained in a 37°C
incubator with 5% CO2. Cells from passages II-IV were used for
all experiments.
Characterization of ASCs
Adipose-derived stem cells were characterized by flow cytome-
try andmultilineage differentiation. For flow cytometry, ASCs in suspen-
sion were incubated with phycoerythrin-coupled antibodies for rat CD31
(BD Pharmingen, San Jose, CA), CD44 (eBioscience Inc, San Diego,
CA), CD45 (BioLegend, San Diego, CA), and CD90 (Acris Antibod-
ies, San Diego, CA) in the dark, at room temperature for 30 minutes.
The cells were washed with wash buffer (0.5% fetal bovine serum in
phosphate-buffered saline) and were fixed in neutral 4% paraformalde-
hyde solution for 30 minutes.
To induce adipogenic and osteogenic differentiation, ASCs were
cultured in adipogenic differentiation medium (StemPro Adipogenesis
Kit, Gibco) and osteogenic differentiation medium (StemPro Osteogen-
esis Kit, Gibco) for 14 and 21 days, respectively. For chondrogenic dif-
ferentiation, ASCs micromass pellets were fed with chondrogenic
differentiation medium that consisted of Dulbecco modified eagle me-
dium with 10-ng/mL transforming GF β-3 [TGFβ-3], and 200-μmol/L
ascorbic acid for 2 weeks. Adipogenic, osteogenic, and chondrogenic
differentiation was confirmed with oil red O, alizarin red staining,
and alcian blue staining, respectively.
SC-like Differentiation of ASCs
We have used a previously published protocol for the SC-like
differentiation of ASCs.7 Adipose-derived stem cells in culture flasksAnnals of Plastic Surgery • Volume 74, Number 5, May 2015
ealth, Inc. All rights reserved.
TABLE 1. Contents of the Differentiation Medium Used in Each Study Group
Groups PDGF (5 ng/mL) bFGF (10 ng/mL) Forskolin (14 μmol/L) GGF (252 ng/mL)
Control − − − −
Group 1 + + + +
Group 2 + + + −
Group 3 + + − +
Group 4 + − + +
Group 5 − + + +
Annals of Plastic Surgery • Volume 74, Number 5, May 2015 Schwann Cell-like Differentiation of ASCswere divided into 6 groups. In the control group, the cells were supple-
mented with cell growth medium (Dulbecco modified eagle medium
+10 % fetal bovine serum +1 % antibiotic/antimycotic solution). In all
the other groups, the cells were initially treated with 1-mmol/L β-
mercaptoethanol for 24 hours and 35-ng/mL all-trans-retinoic acid
(RA) for 72 hours. Afterward, the cells were fed with corresponding dif-
ferentiation medium for 2 weeks (Table 1). Fresh medium was added
every 3 days.Immunofluorescence Staining for SC-Specific Proteins
We carried out immunofluorescence (IF) staining to detect SC-
specific proteins S100, p75, and integrin-β4 in differentiated ASCs.FIGURE 1. Flow cytometric analysis revealed that ASCs expressed M
endothelial cell marker (CD31) and leukocyte marker (CD45).
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2015 Wolters Kluwer HThe cells in each group were fixed with 4% paraformaldehyde and in-
cubated with primary antibodies for S-100 (Acris Antibodies), p75
(Santa Cruz Biotechnology Inc, Santa Cruz, CA), and integrin-β4
(Santa Cruz Biotechnology Inc) for 1 hour at room temperature. Alexa
Fluor 480 (AF480)-labeled antigoat IgG (Invitrogen, Eugene, OR) was
used as secondary antibody. The nuclei were counterstained with
4′,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame,
CA), and the images were captured under a fluorescence microscope.Real-Time qRT-PCR
We detected the fold changes in the gene expression levels of
SC-specific proteins S100, p75, and integrin-β4 in each group withSC markers (CD90 and CD44), but they were negative for
www.annalsplasticsurgery.com 585
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FIGURE 2. Adipose-derived SCs were differentiated into osteogenic (A), adipogenic (B), and chondrogenic (C) lineages to demonstrate
their multipotency. Microbars, 100 μm (A); 50 μm (B, C).
Orbay et al Annals of Plastic Surgery • Volume 74, Number 5, May 2015real-time quantitative reverse transcription (qRT) polymerase chain
reaction (PCR) (qRT-PCR). Primers were TaqMan primers all from
Applied Biosystems. Glyceraldehyde 3-phosphate dehydrogenase was
used as an internal control.FIGURE 3. Results of IF staining after 2 weeks of culturing in different d
intense staining for integrin-β4 and p75 were in groups 3 and 4. The
lower. AF480 was used as secondary antibody and nuclei were count
586 www.annalsplasticsurgery.com
Copyright © 2015 Wolters Kluwer HStatistical Analysis
All results were compared using the one-way analysis of variance
test and, if necessary, the Tukey test (P < 0.05 was considered significant).ifferentiationmediums. In parallel with qRT-PCR results, themost
staining intensities for integrin-β4 and p75 in group 2 were
erstained with 4′,6-diamidino-2-phenylindole. Microbar, 200 μm.
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
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Annals of Plastic Surgery • Volume 74, Number 5, May 2015 Schwann Cell-like Differentiation of ASCsRESULTS
Characterization of ASCs
Adipose-derived stem cells expressed mesenchymal stem cells
(MSC) markers CD90, and CD44 but lacked endothelial cell marker
CD31 and leukocyte marker CD45 on their surface (Fig. 1). Addition-
ally, ASCs differentiated into adipogenic, osteogenic, and chondrogenic
lineages as a proof of their multipotency (Fig. 2).
IF Staining for SC-Specific Proteins
S100 was positive in all the groups, but the staining in groups 1, 3,
4, and 5was stronger than in the other groups (Fig. 3). Theweakest staining
for S100 was in group 2, which lacked glial growth factor (GGF). Staining
for p75 and integrin-β4 was strongest in groups 4 and 5, whereas there
was no staining in undifferentiated ASCs. Overall, the IF staining pat-
terns in groups 4 and 5 were most compatible with SC phenotype.
Real-Time qRT-PCR: Fold Changes in the Expression
Levels of SC Proteins
We used the ΔΔCt method to calculate the fold changes in gene
expression levels relative to the control group. The cells treated with
complete differentiation medium showed a 3.2-, 1.1-, and 1.7-fold in-
crease in expression levels of S100, p75, and integrin-β4, respectively
(Fig. 4). Fold increase in S100 expression in groups 2, 3, 4, and 5 were
1.2; 2.6; 2.7; 0.9, respectively. Overall, the highest expression of S100
was in groups 1, 3, and 4 (P < 0.05). Fold increases in p75 expression
in groups 1 to 5 were 1.1, 1.8, 5.5, 7.6, and 3.7, respectively. The differ-
ence between groups 3 and 4 and the other groups were statistically sig-
nificant (P < 0.05). Fold increases in integrin-β4 expression in groups 1
to 5 were 1.7, 2.1, 5.8, 4.8, and 3.8, with the highest values in groups 3
and 4 (P < 0.05). The expression levels of all SC-specific genes inFIGURE 4. The fold changes in the expression levels of SC-
specific genes were significantly higher in groups 3 and 4 in
comparison to other groups. However, S100 was expressed in
significant levels even in undifferentiated ASCS group.
Differentiationmedium lacking GGF (group 2) did not induce the
expression of SC-specific genes, demonstrating the key role of
GGF in SC-like differentiation. Agarose gel electrophoresis of PCR
product revealed intense bands corresponding to p75 and
integrin-β4 in groups 3 and 4.
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2015 Wolters Kluwer Hgroup 2, which lacked GGF, were significantly lower than groups 3
and 4, demonstrating the key role of GGF in SC-like differentiation
(Fig. 4). The gene expression profile in groups 3 and 4 were most com-
patible with a SC genetic profile.DISCUSSION
The most commonly used differentiation protocol for SC-like
differentiation of ASCs uses a cocktail of forskolin, platelet derived
growth factor (PDGF) and basic fibroblast growth factor (bFGF) after
a pretreatment with β-mercaptoethanol and RA.7 The rationale for
adding GFs to the SC differentiation medium originates from studies
that are carried out mostly on central nervous system cells.15–20 Some
of these GFs have several other functions in other bodily systems. How-
ever, the studies exploring the individual roles of these GFs in the pro-
cess of SC-like differentiation of MSCs are limited.
Basic fibroblast growth factor plays a central role in prolifera-
tion, migration, and differentiation of oligodendrocyte progenitors in
the central nervous system.16,21 In a recent study, Zhu et al claimed that
bFGF is a key regulator of SC-like differentiation of MSCs, but omis-
sion of GGF from the SC differentiation medium did not affect the in-
duction of SC-like phenotype or the expression level of the S100 in
induced MSCs.22 Alone, bFGF could induce SC-like morphological
changes in MSCs and contribute to increased S100 expression. How-
ever, naiveMSCs express neuronal and glial proteins even before differ-
entiation, and S100 expression is mainly modulated by other factors of
the SC-like differentiation medium during the differentiation.23 There-
fore, it is possible to maintain a high level of S100 expression during
SC-like differentiation of MSCs even without bFGF22 as also shown
in our study. Moreover, our data suggested that bFGF has no significant
role in SC-like differentiation of ASCs as group 4, lacking bFGF in dif-
ferentiation medium, still exhibited an increased expression of SC-
specific genes p75 and integrin-β4.
Unlike Zhu et al, we also could not detect any SC-specific pro-
tein expression in GGF-omitted group. GGF, also known as heregulin,
serves as a lineage determination signal that directs neural crest cells to
develop into SC.24 An extensive line of research has revealed that GGF
is crucial for promoting the SC growth and survival, migration along
the extending axon, and myelination.20,25,26 Our data confirmed the
central, indispensable role of GFF in SC-like differentiation of ASCs.
The reason for the discrepancy between our findings and the findings
of Zhu et al can be the different types of MSCs (bone marrow-derived
stem cells vs ASCs) used in these 2 studies, longer duration of differen-
tiation (1 week vs 2 weeks) and also higher concentrations of forskolin
and GGF that we used in our study.
Forskolin stimulates the myelination-associated gene expression
and myelin production in SCs via elevating the intracellular cyclic aden-
osine monophosphate in proliferating SCs.27–30 However, we observed a
satisfactory level of SC-specific protein expression in forskolin (−) group
(group 3), which could be explained by the effects of forskolin mainly fo-
cusing onmyelination. Of note, we did not perform amyelination study or
an animal study to evaluate the function of the SC-like cells differentiated
fromASCs. Therefore, SC-like cells obtained in group 3may not be func-
tional, although they exhibit increased expression of SC-specific genes.
We could not detect any detrimental effect of PDGF omission on
the SC-like differentiation of ASCs. We also could not find strong evi-
dence in the literature to support the importance of PDGF in the SC-like
differentiation process. Stimulation with serum or other GFs including
PDGF, insulin like growth factor, and FGF increased proliferation but
did not induce the expression of myelination-associated genes in SCs.27
An interesting finding suggesting a role for PDGF in SC development
is the increased expression of PDGF receptors on SC precursor cells.
However, increased receptor expression was uncorrelated with the pro-
liferation or differentiation of SC precursors in the peripheral nervous
system, suggesting a different role of PDGF in SC development.31www.annalsplasticsurgery.com 587
ealth, Inc. All rights reserved.
Orbay et al Annals of Plastic Surgery • Volume 74, Number 5, May 2015In conclusion, our data suggested that GGF is a key component
of SC-like differentiationmedium, but the omission of bFGFand PDGF
from the differentiation medium did not have a significant detrimental
effect on the SC-like differentiation of ASCs.
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